Parnassus Investments’s Roivant Sciences ROIV Stock Holding History

Parnassus Investments’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Buy	+367,212	New	+$10.9M	0.03%	117

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

CPRC

Consolidated Portfolio Review Corp Woodbury, New York $1.2B AUM 13.59% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Parnassus Investments's ROIV Position: Q2 2026 in Review

Parnassus Investments opened a new position in Roivant Sciences (ROIV) in Q2 2026: 367,212 shares worth $13M. The stake represents 0.03% of the portfolio and ranks #117 among its holdings.

125 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Parnassus Investments held 367,212 shares of Roivant Sciences worth $13M as of Q2 2026.
Roivant Sciences was a new Parnassus Investments position in Q2 2026.
Roivant Sciences made up 0.03% of Parnassus Investments's portfolio in Q2 2026, its #117 holding.
125 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.